Index
1 Market Overview
1.1 Product Overview and Scope of Nanotechnology-based Drug Delivery
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Nanotechnology-based Drug Delivery by Type
1.3.1 Overview: Global Nanotechnology-based Drug Delivery Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global Nanotechnology-based Drug Delivery Consumption Value Market Share by Type in 2022
1.3.3 Nanocrystals
1.3.4 Nanoparticles
1.3.5 Liposomes
1.3.6 Micelles
1.3.7 Others
1.4 Global Nanotechnology-based Drug Delivery Market by Application
1.4.1 Overview: Global Nanotechnology-based Drug Delivery Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospital
1.4.3 Research Institute
1.4.4 Others
1.5 Global Nanotechnology-based Drug Delivery Market Size & Forecast
1.6 Global Nanotechnology-based Drug Delivery Market Size and Forecast by Region
1.6.1 Global Nanotechnology-based Drug Delivery Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global Nanotechnology-based Drug Delivery Market Size by Region, (2018-2029)
1.6.3 North America Nanotechnology-based Drug Delivery Market Size and Prospect (2018-2029)
1.6.4 Europe Nanotechnology-based Drug Delivery Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific Nanotechnology-based Drug Delivery Market Size and Prospect (2018-2029)
1.6.6 South America Nanotechnology-based Drug Delivery Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa Nanotechnology-based Drug Delivery Market Size and Prospect (2018-2029)
2 Company Profiles
2.1 AbbVie Inc.
2.1.1 AbbVie Inc. Details
2.1.2 AbbVie Inc. Major Business
2.1.3 AbbVie Inc. Nanotechnology-based Drug Delivery Product and Solutions
2.1.4 AbbVie Inc. Nanotechnology-based Drug Delivery Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 AbbVie Inc. Recent Developments and Future Plans
2.2 BlueWillow Biologics Inc.
2.2.1 BlueWillow Biologics Inc. Details
2.2.2 BlueWillow Biologics Inc. Major Business
2.2.3 BlueWillow Biologics Inc. Nanotechnology-based Drug Delivery Product and Solutions
2.2.4 BlueWillow Biologics Inc. Nanotechnology-based Drug Delivery Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 BlueWillow Biologics Inc. Recent Developments and Future Plans
2.3 Camurus AB
2.3.1 Camurus AB Details
2.3.2 Camurus AB Major Business
2.3.3 Camurus AB Nanotechnology-based Drug Delivery Product and Solutions
2.3.4 Camurus AB Nanotechnology-based Drug Delivery Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Camurus AB Recent Developments and Future Plans
2.4 Celgene, lnc.
2.4.1 Celgene, lnc. Details
2.4.2 Celgene, lnc. Major Business
2.4.3 Celgene, lnc. Nanotechnology-based Drug Delivery Product and Solutions
2.4.4 Celgene, lnc. Nanotechnology-based Drug Delivery Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Celgene, lnc. Recent Developments and Future Plans
2.5 Cristal Therapeutics
2.5.1 Cristal Therapeutics Details
2.5.2 Cristal Therapeutics Major Business
2.5.3 Cristal Therapeutics Nanotechnology-based Drug Delivery Product and Solutions
2.5.4 Cristal Therapeutics Nanotechnology-based Drug Delivery Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Cristal Therapeutics Recent Developments and Future Plans
2.6 EyePoint Pharmaceuticals
2.6.1 EyePoint Pharmaceuticals Details
2.6.2 EyePoint Pharmaceuticals Major Business
2.6.3 EyePoint Pharmaceuticals Nanotechnology-based Drug Delivery Product and Solutions
2.6.4 EyePoint Pharmaceuticals Nanotechnology-based Drug Delivery Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 EyePoint Pharmaceuticals Recent Developments and Future Plans
2.7 Johnson and Johnson
2.7.1 Johnson and Johnson Details
2.7.2 Johnson and Johnson Major Business
2.7.3 Johnson and Johnson Nanotechnology-based Drug Delivery Product and Solutions
2.7.4 Johnson and Johnson Nanotechnology-based Drug Delivery Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Johnson and Johnson Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Nanotechnology-based Drug Delivery Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of Nanotechnology-based Drug Delivery by Company Revenue
3.2.2 Top 3 Nanotechnology-based Drug Delivery Players Market Share in 2022
3.2.3 Top 6 Nanotechnology-based Drug Delivery Players Market Share in 2022
3.3 Nanotechnology-based Drug Delivery Market: Overall Company Footprint Analysis
3.3.1 Nanotechnology-based Drug Delivery Market: Region Footprint
3.3.2 Nanotechnology-based Drug Delivery Market: Company Product Type Footprint
3.3.3 Nanotechnology-based Drug Delivery Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
4.1 Global Nanotechnology-based Drug Delivery Consumption Value and Market Share by Type (2018-2023)
4.2 Global Nanotechnology-based Drug Delivery Market Forecast by Type (2024-2029)
5 Market Size Segment by Application
5.1 Global Nanotechnology-based Drug Delivery Consumption Value Market Share by Application (2018-2023)
5.2 Global Nanotechnology-based Drug Delivery Market Forecast by Application (2024-2029)
6 North America
6.1 North America Nanotechnology-based Drug Delivery Consumption Value by Type (2018-2029)
6.2 North America Nanotechnology-based Drug Delivery Consumption Value by Application (2018-2029)
6.3 North America Nanotechnology-based Drug Delivery Market Size by Country
6.3.1 North America Nanotechnology-based Drug Delivery Consumption Value by Country (2018-2029)
6.3.2 United States Nanotechnology-based Drug Delivery Market Size and Forecast (2018-2029)
6.3.3 Canada Nanotechnology-based Drug Delivery Market Size and Forecast (2018-2029)
6.3.4 Mexico Nanotechnology-based Drug Delivery Market Size and Forecast (2018-2029)
7 Europe
7.1 Europe Nanotechnology-based Drug Delivery Consumption Value by Type (2018-2029)
7.2 Europe Nanotechnology-based Drug Delivery Consumption Value by Application (2018-2029)
7.3 Europe Nanotechnology-based Drug Delivery Market Size by Country
7.3.1 Europe Nanotechnology-based Drug Delivery Consumption Value by Country (2018-2029)
7.3.2 Germany Nanotechnology-based Drug Delivery Market Size and Forecast (2018-2029)
7.3.3 France Nanotechnology-based Drug Delivery Market Size and Forecast (2018-2029)
7.3.4 United Kingdom Nanotechnology-based Drug Delivery Market Size and Forecast (2018-2029)
7.3.5 Russia Nanotechnology-based Drug Delivery Market Size and Forecast (2018-2029)
7.3.6 Italy Nanotechnology-based Drug Delivery Market Size and Forecast (2018-2029)
8 Asia-Pacific
8.1 Asia-Pacific Nanotechnology-based Drug Delivery Consumption Value by Type (2018-2029)
8.2 Asia-Pacific Nanotechnology-based Drug Delivery Consumption Value by Application (2018-2029)
8.3 Asia-Pacific Nanotechnology-based Drug Delivery Market Size by Region
8.3.1 Asia-Pacific Nanotechnology-based Drug Delivery Consumption Value by Region (2018-2029)
8.3.2 China Nanotechnology-based Drug Delivery Market Size and Forecast (2018-2029)
8.3.3 Japan Nanotechnology-based Drug Delivery Market Size and Forecast (2018-2029)
8.3.4 South Korea Nanotechnology-based Drug Delivery Market Size and Forecast (2018-2029)
8.3.5 India Nanotechnology-based Drug Delivery Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia Nanotechnology-based Drug Delivery Market Size and Forecast (2018-2029)
8.3.7 Australia Nanotechnology-based Drug Delivery Market Size and Forecast (2018-2029)
9 South America
9.1 South America Nanotechnology-based Drug Delivery Consumption Value by Type (2018-2029)
9.2 South America Nanotechnology-based Drug Delivery Consumption Value by Application (2018-2029)
9.3 South America Nanotechnology-based Drug Delivery Market Size by Country
9.3.1 South America Nanotechnology-based Drug Delivery Consumption Value by Country (2018-2029)
9.3.2 Brazil Nanotechnology-based Drug Delivery Market Size and Forecast (2018-2029)
9.3.3 Argentina Nanotechnology-based Drug Delivery Market Size and Forecast (2018-2029)
10 Middle East & Africa
10.1 Middle East & Africa Nanotechnology-based Drug Delivery Consumption Value by Type (2018-2029)
10.2 Middle East & Africa Nanotechnology-based Drug Delivery Consumption Value by Application (2018-2029)
10.3 Middle East & Africa Nanotechnology-based Drug Delivery Market Size by Country
10.3.1 Middle East & Africa Nanotechnology-based Drug Delivery Consumption Value by Country (2018-2029)
10.3.2 Turkey Nanotechnology-based Drug Delivery Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia Nanotechnology-based Drug Delivery Market Size and Forecast (2018-2029)
10.3.4 UAE Nanotechnology-based Drug Delivery Market Size and Forecast (2018-2029)
11 Market Dynamics
11.1 Nanotechnology-based Drug Delivery Market Drivers
11.2 Nanotechnology-based Drug Delivery Market Restraints
11.3 Nanotechnology-based Drug Delivery Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
11.5.1 Influence of COVID-19
11.5.2 Influence of Russia-Ukraine War
12 Industry Chain Analysis
12.1 Nanotechnology-based Drug Delivery Industry Chain
12.2 Nanotechnology-based Drug Delivery Upstream Analysis
12.3 Nanotechnology-based Drug Delivery Midstream Analysis
12.4 Nanotechnology-based Drug Delivery Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer